nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylthiouracil—MPO—hematologic cancer	0.497	1	CbGaD
Propylthiouracil—MPO—Cisplatin—hematologic cancer	0.0316	1	CbGbCtD
Propylthiouracil—DIO1—lung—hematologic cancer	0.011	0.18	CbGeAlD
Propylthiouracil—DIO1—testis—hematologic cancer	0.0104	0.17	CbGeAlD
Propylthiouracil—TPO—hematopoietic system—hematologic cancer	0.00854	0.14	CbGeAlD
Propylthiouracil—DBH—hematopoietic system—hematologic cancer	0.00557	0.0912	CbGeAlD
Propylthiouracil—TPO—testis—hematologic cancer	0.00468	0.0766	CbGeAlD
Propylthiouracil—DBH—blood—hematologic cancer	0.00369	0.0604	CbGeAlD
Propylthiouracil—DBH—bone marrow—hematologic cancer	0.00357	0.0585	CbGeAlD
Propylthiouracil—MPO—hematopoietic system—hematologic cancer	0.00298	0.0488	CbGeAlD
Propylthiouracil—DBH—lymph node—hematologic cancer	0.00221	0.0362	CbGeAlD
Propylthiouracil—MPO—blood—hematologic cancer	0.00197	0.0323	CbGeAlD
Propylthiouracil—MPO—bone marrow—hematologic cancer	0.00191	0.0313	CbGeAlD
Propylthiouracil—MPO—lung—hematologic cancer	0.00173	0.0283	CbGeAlD
Propylthiouracil—MPO—testis—hematologic cancer	0.00163	0.0267	CbGeAlD
Propylthiouracil—MPO—lymph node—hematologic cancer	0.00118	0.0194	CbGeAlD
Propylthiouracil—MPO—Vitamin B12 Metabolism—SOD2—hematologic cancer	0.00038	0.0025	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—NFKBIA—hematologic cancer	0.000376	0.00246	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—MTR—hematologic cancer	0.000374	0.00245	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—GATA3—hematologic cancer	0.000367	0.00241	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—IL1B—hematologic cancer	0.000357	0.00234	CbGpPWpGaD
Propylthiouracil—DBH—Monoamine Transport—TNF—hematologic cancer	0.000355	0.00233	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—MTR—hematologic cancer	0.000351	0.00231	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDK6—hematologic cancer	0.000348	0.00228	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—CCL2—hematologic cancer	0.000339	0.00222	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—MTHFR—hematologic cancer	0.000335	0.0022	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GMPS—hematologic cancer	0.000332	0.00218	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—FTCD—hematologic cancer	0.000332	0.00218	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PHYH—hematologic cancer	0.000332	0.00218	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—CRP—hematologic cancer	0.000319	0.00209	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—SOD2—hematologic cancer	0.00031	0.00203	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SMPD3—hematologic cancer	0.000304	0.00199	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3R1—hematologic cancer	0.000302	0.00198	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL4—hematologic cancer	0.0003	0.00197	CbGpPWpGaD
Propylthiouracil—DBH—Amino acid and derivative metabolism—NQO1—hematologic cancer	0.000295	0.00194	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—JAK2—hematologic cancer	0.000294	0.00193	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—ICAM1—hematologic cancer	0.000293	0.00192	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IFNG—hematologic cancer	0.000288	0.00189	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—VEGFA—hematologic cancer	0.000282	0.00185	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—CD4—hematologic cancer	0.000278	0.00183	CbGpPWpGaD
Propylthiouracil—TPO—Amino acid and derivative metabolism—NQO1—hematologic cancer	0.000278	0.00182	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—KITLG—hematologic cancer	0.000277	0.00181	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—MTHFR—hematologic cancer	0.000273	0.00179	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—DCK—hematologic cancer	0.000265	0.00174	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—B3GAT1—hematologic cancer	0.000265	0.00174	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ASNS—hematologic cancer	0.000265	0.00174	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—CCL2—hematologic cancer	0.000262	0.00172	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—CRP—hematologic cancer	0.000259	0.0017	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—TNF—hematologic cancer	0.000259	0.0017	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—TGFB1—hematologic cancer	0.000259	0.0017	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL1B—hematologic cancer	0.000257	0.00169	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL2—hematologic cancer	0.000256	0.00168	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—HES1—hematologic cancer	0.000256	0.00168	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—GSTM1—hematologic cancer	0.000254	0.00167	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—NCOR1—hematologic cancer	0.000254	0.00167	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HDC—hematologic cancer	0.000252	0.00165	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—SOD2—hematologic cancer	0.000246	0.00161	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—ALB—hematologic cancer	0.000244	0.0016	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—ICAM1—hematologic cancer	0.000238	0.00156	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CDA—hematologic cancer	0.00023	0.00151	CbGpPWpGaD
Propylthiouracil—TPO—Hematopoietic Stem Cell Differentiation—IL6—hematologic cancer	0.000226	0.00148	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IFNG—hematologic cancer	0.000223	0.00146	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PC—hematologic cancer	0.000221	0.00145	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—MTHFR—hematologic cancer	0.000217	0.00142	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—STAT3—hematologic cancer	0.000215	0.00141	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SLC35B2—hematologic cancer	0.000214	0.0014	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GBA—hematologic cancer	0.000214	0.0014	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—CCL2—hematologic cancer	0.000213	0.0014	CbGpPWpGaD
Propylthiouracil—DIO1—Selenium Micronutrient Network—IL6—hematologic cancer	0.000209	0.00137	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—CRP—hematologic cancer	0.000206	0.00135	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PHYH—hematologic cancer	0.000203	0.00133	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—FTCD—hematologic cancer	0.000203	0.00133	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GMPS—hematologic cancer	0.000203	0.00133	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL1B—hematologic cancer	0.000199	0.0013	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—ALB—hematologic cancer	0.000199	0.0013	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—MTAP—hematologic cancer	0.000196	0.00128	CbGpPWpGaD
Propylthiouracil—TPO—Differentiation Pathway—IL6—hematologic cancer	0.000195	0.00128	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GMPS—hematologic cancer	0.000191	0.00125	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PHYH—hematologic cancer	0.000191	0.00125	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—FTCD—hematologic cancer	0.000191	0.00125	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—ICAM1—hematologic cancer	0.000189	0.00124	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—KIT—hematologic cancer	0.000189	0.00124	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—TNF—hematologic cancer	0.000186	0.00122	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SMPD3—hematologic cancer	0.000185	0.00122	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IFNG—hematologic cancer	0.000181	0.00119	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CREBBP—hematologic cancer	0.000175	0.00115	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—FHL2—hematologic cancer	0.000174	0.00114	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SMPD3—hematologic cancer	0.000174	0.00114	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AGRN—hematologic cancer	0.000171	0.00112	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—PIK3CA—hematologic cancer	0.00017	0.00111	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—CCL2—hematologic cancer	0.000169	0.00111	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—DCK—hematologic cancer	0.000162	0.00106	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—IDH2—hematologic cancer	0.000162	0.00106	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ASNS—hematologic cancer	0.000162	0.00106	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—B3GAT1—hematologic cancer	0.000162	0.00106	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—HMMR—hematologic cancer	0.000162	0.00106	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL1B—hematologic cancer	0.000162	0.00106	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—IL2—hematologic cancer	0.000161	0.00106	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—ALB—hematologic cancer	0.000158	0.00104	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HDC—hematologic cancer	0.000154	0.00101	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN2A—hematologic cancer	0.000153	0.00101	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ARNTL—hematologic cancer	0.000152	0.001	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—B3GAT1—hematologic cancer	0.000152	0.001	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—DCK—hematologic cancer	0.000152	0.001	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ASNS—hematologic cancer	0.000152	0.001	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—BCL2—hematologic cancer	0.000151	0.00099	CbGpPWpGaD
Propylthiouracil—MPO—IL23-mediated signaling events—IL6—hematologic cancer	0.00015	0.000987	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CA9—hematologic cancer	0.000148	0.000972	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ACP5—hematologic cancer	0.000148	0.000972	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NCOR2—hematologic cancer	0.000146	0.00096	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HDC—hematologic cancer	0.000144	0.000948	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CD4—hematologic cancer	0.000144	0.000947	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—TNF—hematologic cancer	0.000144	0.000946	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IFNG—hematologic cancer	0.000144	0.000945	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CDA—hematologic cancer	0.000141	0.000922	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—IDH1—hematologic cancer	0.000139	0.000914	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ABCC3—hematologic cancer	0.000138	0.000904	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTO1—hematologic cancer	0.000138	0.000904	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—TXN—hematologic cancer	0.000138	0.000904	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1B—hematologic cancer	0.000136	0.000891	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PC—hematologic cancer	0.000135	0.000887	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SPHK1—hematologic cancer	0.000135	0.000885	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CDA—hematologic cancer	0.000132	0.000867	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GBA—hematologic cancer	0.000131	0.000857	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SLC35B2—hematologic cancer	0.000131	0.000857	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—UGT1A1—hematologic cancer	0.00013	0.00085	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CCND1—hematologic cancer	0.00013	0.00085	CbGpPWpGaD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL1B—hematologic cancer	0.000128	0.000843	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PC—hematologic cancer	0.000127	0.000834	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CRABP1—hematologic cancer	0.000126	0.000827	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SLC22A1—hematologic cancer	0.000126	0.000827	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—CDKN1A—hematologic cancer	0.000125	0.000822	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GBA—hematologic cancer	0.000123	0.000806	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC35B2—hematologic cancer	0.000123	0.000806	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ALOX5—hematologic cancer	0.000123	0.000806	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTAP—hematologic cancer	0.00012	0.000784	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—EP300—hematologic cancer	0.000119	0.000782	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NUP98—hematologic cancer	0.000119	0.00078	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TNF—hematologic cancer	0.000117	0.00077	CbGpPWpGaD
Propylthiouracil—MPO—Vitamin B12 Metabolism—IL6—hematologic cancer	0.000116	0.000764	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ADCY7—hematologic cancer	0.000116	0.000758	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NCOA3—hematologic cancer	0.000116	0.000758	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NUP214—hematologic cancer	0.000115	0.000752	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ABCG2—hematologic cancer	0.000112	0.000737	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—MTR—hematologic cancer	0.000112	0.000737	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTAP—hematologic cancer	0.000112	0.000737	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—NRAS—hematologic cancer	0.000112	0.000732	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—ENO2—hematologic cancer	0.00011	0.000723	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTT1—hematologic cancer	0.000107	0.000701	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—FHL2—hematologic cancer	0.000107	0.000699	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—SDC1—hematologic cancer	0.000104	0.000685	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AGRN—hematologic cancer	0.000104	0.000685	CbGpPWpGaD
Propylthiouracil—MPO—C-MYB transcription factor network—MYC—hematologic cancer	0.000104	0.000681	CbGpPWpGaD
Propylthiouracil—MPO—Folate Metabolism—TP53—hematologic cancer	0.000103	0.000679	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—FHL2—hematologic cancer	0.0001	0.000657	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—IDH2—hematologic cancer	9.9e-05	0.00065	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HMMR—hematologic cancer	9.9e-05	0.00065	CbGpPWpGaD
Propylthiouracil—Alopecia—Betamethasone—hematologic cancer	9.86e-05	0.000383	CcSEcCtD
Propylthiouracil—Alopecia—Dexamethasone—hematologic cancer	9.86e-05	0.000383	CcSEcCtD
Propylthiouracil—Rash—Lenalidomide—hematologic cancer	9.85e-05	0.000382	CcSEcCtD
Propylthiouracil—Body temperature increased—Carmustine—hematologic cancer	9.85e-05	0.000382	CcSEcCtD
Propylthiouracil—Dermatitis—Lenalidomide—hematologic cancer	9.84e-05	0.000382	CcSEcCtD
Propylthiouracil—TPO—Metabolism—AGRN—hematologic cancer	9.82e-05	0.000644	CbGpPWpGaD
Propylthiouracil—Urticaria—Alitretinoin—hematologic cancer	9.8e-05	0.00038	CcSEcCtD
Propylthiouracil—Vomiting—Hydroxyurea—hematologic cancer	9.8e-05	0.00038	CcSEcCtD
Propylthiouracil—Headache—Lenalidomide—hematologic cancer	9.79e-05	0.00038	CcSEcCtD
Propylthiouracil—Haemoglobin—Prednisone—hematologic cancer	9.77e-05	0.000379	CcSEcCtD
Propylthiouracil—Body temperature increased—Alitretinoin—hematologic cancer	9.75e-05	0.000379	CcSEcCtD
Propylthiouracil—Haemorrhage—Prednisone—hematologic cancer	9.72e-05	0.000377	CcSEcCtD
Propylthiouracil—Rash—Hydroxyurea—hematologic cancer	9.71e-05	0.000377	CcSEcCtD
Propylthiouracil—Dermatitis—Hydroxyurea—hematologic cancer	9.71e-05	0.000377	CcSEcCtD
Propylthiouracil—Urticaria—Ifosfamide—hematologic cancer	9.69e-05	0.000376	CcSEcCtD
Propylthiouracil—Headache—Hydroxyurea—hematologic cancer	9.65e-05	0.000375	CcSEcCtD
Propylthiouracil—Body temperature increased—Ifosfamide—hematologic cancer	9.64e-05	0.000374	CcSEcCtD
Propylthiouracil—Vertigo—Triamcinolone—hematologic cancer	9.62e-05	0.000373	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—KRAS—hematologic cancer	9.6e-05	0.00063	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Cisplatin—hematologic cancer	9.58e-05	0.000372	CcSEcCtD
Propylthiouracil—Nausea—Melphalan—hematologic cancer	9.55e-05	0.00037	CcSEcCtD
Propylthiouracil—Oedema—Prednisolone—hematologic cancer	9.5e-05	0.000369	CcSEcCtD
Propylthiouracil—Pruritus—Thiotepa—hematologic cancer	9.49e-05	0.000368	CcSEcCtD
Propylthiouracil—MPO—Folate Metabolism—IL6—hematologic cancer	9.47e-05	0.000621	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Cisplatin—hematologic cancer	9.44e-05	0.000366	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Etoposide—hematologic cancer	9.43e-05	0.000366	CcSEcCtD
Propylthiouracil—Body temperature increased—Vincristine—hematologic cancer	9.4e-05	0.000365	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—TNF—hematologic cancer	9.32e-05	0.000612	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ARNTL—hematologic cancer	9.31e-05	0.000611	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—IDH2—hematologic cancer	9.31e-05	0.000611	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—HMMR—hematologic cancer	9.31e-05	0.000611	CbGpPWpGaD
Propylthiouracil—Nausea—Lenalidomide—hematologic cancer	9.28e-05	0.00036	CcSEcCtD
Propylthiouracil—Urticaria—Mitoxantrone—hematologic cancer	9.2e-05	0.000357	CcSEcCtD
Propylthiouracil—Pruritus—Thalidomide—hematologic cancer	9.17e-05	0.000356	CcSEcCtD
Propylthiouracil—Body temperature increased—Irinotecan—hematologic cancer	9.15e-05	0.000355	CcSEcCtD
Propylthiouracil—Body temperature increased—Mitoxantrone—hematologic cancer	9.15e-05	0.000355	CcSEcCtD
Propylthiouracil—Nausea—Hydroxyurea—hematologic cancer	9.15e-05	0.000355	CcSEcCtD
Propylthiouracil—Vomiting—Bortezomib—hematologic cancer	9.14e-05	0.000355	CcSEcCtD
Propylthiouracil—Myalgia—Triamcinolone—hematologic cancer	9.11e-05	0.000354	CcSEcCtD
Propylthiouracil—Vomiting—Bleomycin—hematologic cancer	9.07e-05	0.000352	CcSEcCtD
Propylthiouracil—Rash—Bortezomib—hematologic cancer	9.07e-05	0.000352	CcSEcCtD
Propylthiouracil—Dermatitis—Bortezomib—hematologic cancer	9.06e-05	0.000352	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ACP5—hematologic cancer	9.06e-05	0.000594	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CA9—hematologic cancer	9.06e-05	0.000594	CbGpPWpGaD
Propylthiouracil—Drowsiness—Methotrexate—hematologic cancer	9.05e-05	0.000351	CcSEcCtD
Propylthiouracil—Headache—Bortezomib—hematologic cancer	9.01e-05	0.00035	CcSEcCtD
Propylthiouracil—Rash—Bleomycin—hematologic cancer	9e-05	0.000349	CcSEcCtD
Propylthiouracil—Dermatitis—Bleomycin—hematologic cancer	8.99e-05	0.000349	CcSEcCtD
Propylthiouracil—DBH—Metabolism—NCOR2—hematologic cancer	8.94e-05	0.000586	CbGpPWpGaD
Propylthiouracil—Vomiting—Vinorelbine—hematologic cancer	8.93e-05	0.000346	CcSEcCtD
Propylthiouracil—Body temperature increased—Gemcitabine—hematologic cancer	8.92e-05	0.000346	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CD44—hematologic cancer	8.88e-05	0.000583	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NQO1—hematologic cancer	8.88e-05	0.000583	CbGpPWpGaD
Propylthiouracil—Rash—Vinorelbine—hematologic cancer	8.85e-05	0.000344	CcSEcCtD
Propylthiouracil—Dermatitis—Vinorelbine—hematologic cancer	8.84e-05	0.000343	CcSEcCtD
Propylthiouracil—Headache—Vinorelbine—hematologic cancer	8.8e-05	0.000341	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ARNTL—hematologic cancer	8.75e-05	0.000574	CbGpPWpGaD
Propylthiouracil—Oedema—Triamcinolone—hematologic cancer	8.74e-05	0.000339	CcSEcCtD
Propylthiouracil—Pruritus—Alitretinoin—hematologic cancer	8.73e-05	0.000339	CcSEcCtD
Propylthiouracil—Vertigo—Betamethasone—hematologic cancer	8.73e-05	0.000339	CcSEcCtD
Propylthiouracil—Vertigo—Dexamethasone—hematologic cancer	8.73e-05	0.000339	CcSEcCtD
Propylthiouracil—Paraesthesia—Etoposide—hematologic cancer	8.65e-05	0.000336	CcSEcCtD
Propylthiouracil—Pruritus—Ifosfamide—hematologic cancer	8.63e-05	0.000335	CcSEcCtD
Propylthiouracil—Alopecia—Prednisone—hematologic cancer	8.59e-05	0.000333	CcSEcCtD
Propylthiouracil—Somnolence—Etoposide—hematologic cancer	8.56e-05	0.000332	CcSEcCtD
Propylthiouracil—Nausea—Bortezomib—hematologic cancer	8.54e-05	0.000331	CcSEcCtD
Propylthiouracil—Paraesthesia—Prednisolone—hematologic cancer	8.53e-05	0.000331	CcSEcCtD
Propylthiouracil—Vomiting—Thiotepa—hematologic cancer	8.52e-05	0.000331	CcSEcCtD
Propylthiouracil—DBH—Metabolism—IDH1—hematologic cancer	8.52e-05	0.000559	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ACP5—hematologic cancer	8.52e-05	0.000559	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CA9—hematologic cancer	8.52e-05	0.000559	CbGpPWpGaD
Propylthiouracil—Nausea—Bleomycin—hematologic cancer	8.48e-05	0.000329	CcSEcCtD
Propylthiouracil—Drowsiness—Epirubicin—hematologic cancer	8.46e-05	0.000329	CcSEcCtD
Propylthiouracil—Rash—Thiotepa—hematologic cancer	8.45e-05	0.000328	CcSEcCtD
Propylthiouracil—Dermatitis—Thiotepa—hematologic cancer	8.45e-05	0.000328	CcSEcCtD
Propylthiouracil—Agranulocytosis—Methotrexate—hematologic cancer	8.44e-05	0.000328	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTO1—hematologic cancer	8.42e-05	0.000552	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ABCC3—hematologic cancer	8.42e-05	0.000552	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—TXN—hematologic cancer	8.42e-05	0.000552	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—CYCS—hematologic cancer	8.4e-05	0.000551	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NCOR2—hematologic cancer	8.4e-05	0.000551	CbGpPWpGaD
Propylthiouracil—Headache—Thiotepa—hematologic cancer	8.4e-05	0.000326	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—HSP90AA1—hematologic cancer	8.35e-05	0.000548	CbGpPWpGaD
Propylthiouracil—Nausea—Vinorelbine—hematologic cancer	8.34e-05	0.000324	CcSEcCtD
Propylthiouracil—Body temperature increased—Cisplatin—hematologic cancer	8.31e-05	0.000323	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Epirubicin—hematologic cancer	8.3e-05	0.000322	CcSEcCtD
Propylthiouracil—Myalgia—Betamethasone—hematologic cancer	8.27e-05	0.000321	CcSEcCtD
Propylthiouracil—Myalgia—Dexamethasone—hematologic cancer	8.27e-05	0.000321	CcSEcCtD
Propylthiouracil—Jaundice—Epirubicin—hematologic cancer	8.25e-05	0.00032	CcSEcCtD
Propylthiouracil—Vomiting—Thalidomide—hematologic cancer	8.25e-05	0.00032	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SPHK1—hematologic cancer	8.24e-05	0.00054	CbGpPWpGaD
Propylthiouracil—Rash—Thalidomide—hematologic cancer	8.18e-05	0.000317	CcSEcCtD
Propylthiouracil—Dermatitis—Thalidomide—hematologic cancer	8.17e-05	0.000317	CcSEcCtD
Propylthiouracil—Haemoglobin—Methotrexate—hematologic cancer	8.16e-05	0.000317	CcSEcCtD
Propylthiouracil—MPO—C-MYB transcription factor network—HRAS—hematologic cancer	8.16e-05	0.000535	CbGpPWpGaD
Propylthiouracil—Headache—Thalidomide—hematologic cancer	8.12e-05	0.000315	CcSEcCtD
Propylthiouracil—Hepatitis—Methotrexate—hematologic cancer	8.12e-05	0.000315	CcSEcCtD
Propylthiouracil—Haemorrhage—Methotrexate—hematologic cancer	8.12e-05	0.000315	CcSEcCtD
Propylthiouracil—TPO—Metabolism—IDH1—hematologic cancer	8.01e-05	0.000525	CbGpPWpGaD
Propylthiouracil—Pruritus—Gemcitabine—hematologic cancer	7.98e-05	0.00031	CcSEcCtD
Propylthiouracil—Nausea—Thiotepa—hematologic cancer	7.96e-05	0.000309	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Triamcinolone—hematologic cancer	7.96e-05	0.000309	CcSEcCtD
Propylthiouracil—Oedema—Dexamethasone—hematologic cancer	7.93e-05	0.000308	CcSEcCtD
Propylthiouracil—Oedema—Betamethasone—hematologic cancer	7.93e-05	0.000308	CcSEcCtD
Propylthiouracil—Vomiting—Carmustine—hematologic cancer	7.92e-05	0.000307	CcSEcCtD
Propylthiouracil—DBH—Metabolism—UGT1A1—hematologic cancer	7.92e-05	0.000519	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ABCC3—hematologic cancer	7.92e-05	0.000519	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—GSTO1—hematologic cancer	7.92e-05	0.000519	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—TXN—hematologic cancer	7.92e-05	0.000519	CbGpPWpGaD
Propylthiouracil—Agranulocytosis—Epirubicin—hematologic cancer	7.9e-05	0.000307	CcSEcCtD
Propylthiouracil—Rash—Carmustine—hematologic cancer	7.85e-05	0.000305	CcSEcCtD
Propylthiouracil—Dermatitis—Carmustine—hematologic cancer	7.85e-05	0.000305	CcSEcCtD
Propylthiouracil—Vomiting—Alitretinoin—hematologic cancer	7.85e-05	0.000304	CcSEcCtD
Propylthiouracil—Paraesthesia—Triamcinolone—hematologic cancer	7.84e-05	0.000304	CcSEcCtD
Propylthiouracil—Drowsiness—Doxorubicin—hematologic cancer	7.83e-05	0.000304	CcSEcCtD
Propylthiouracil—Headache—Carmustine—hematologic cancer	7.8e-05	0.000303	CcSEcCtD
Propylthiouracil—Rash—Alitretinoin—hematologic cancer	7.78e-05	0.000302	CcSEcCtD
Propylthiouracil—Dermatitis—Alitretinoin—hematologic cancer	7.77e-05	0.000302	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Betamethasone—hematologic cancer	7.76e-05	0.000301	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Dexamethasone—hematologic cancer	7.76e-05	0.000301	CcSEcCtD
Propylthiouracil—Vomiting—Ifosfamide—hematologic cancer	7.75e-05	0.000301	CcSEcCtD
Propylthiouracil—TPO—Metabolism—SPHK1—hematologic cancer	7.75e-05	0.000508	CbGpPWpGaD
Propylthiouracil—Headache—Alitretinoin—hematologic cancer	7.73e-05	0.0003	CcSEcCtD
Propylthiouracil—Nausea—Thalidomide—hematologic cancer	7.7e-05	0.000299	CcSEcCtD
Propylthiouracil—DBH—Metabolism—SLC22A1—hematologic cancer	7.7e-05	0.000505	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CRABP1—hematologic cancer	7.7e-05	0.000505	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Triamcinolone—hematologic cancer	7.69e-05	0.000298	CcSEcCtD
Propylthiouracil—Rash—Ifosfamide—hematologic cancer	7.69e-05	0.000298	CcSEcCtD
Propylthiouracil—Dermatitis—Ifosfamide—hematologic cancer	7.68e-05	0.000298	CcSEcCtD
Propylthiouracil—Neuropathy peripheral—Doxorubicin—hematologic cancer	7.68e-05	0.000298	CcSEcCtD
Propylthiouracil—Urticaria—Etoposide—hematologic cancer	7.65e-05	0.000297	CcSEcCtD
Propylthiouracil—Haemoglobin—Epirubicin—hematologic cancer	7.64e-05	0.000296	CcSEcCtD
Propylthiouracil—Jaundice—Doxorubicin—hematologic cancer	7.63e-05	0.000296	CcSEcCtD
Propylthiouracil—Body temperature increased—Etoposide—hematologic cancer	7.61e-05	0.000296	CcSEcCtD
Propylthiouracil—Vertigo—Prednisone—hematologic cancer	7.6e-05	0.000295	CcSEcCtD
Propylthiouracil—Hepatitis—Epirubicin—hematologic cancer	7.6e-05	0.000295	CcSEcCtD
Propylthiouracil—Haemorrhage—Epirubicin—hematologic cancer	7.6e-05	0.000295	CcSEcCtD
Propylthiouracil—Vomiting—Vincristine—hematologic cancer	7.56e-05	0.000293	CcSEcCtD
Propylthiouracil—Urticaria—Prednisolone—hematologic cancer	7.55e-05	0.000293	CcSEcCtD
Propylthiouracil—MPO—Selenium Micronutrient Network—IL6—hematologic cancer	7.52e-05	0.000494	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALOX5—hematologic cancer	7.5e-05	0.000492	CbGpPWpGaD
Propylthiouracil—Rash—Vincristine—hematologic cancer	7.5e-05	0.000291	CcSEcCtD
Propylthiouracil—Dermatitis—Vincristine—hematologic cancer	7.49e-05	0.000291	CcSEcCtD
Propylthiouracil—Headache—Vincristine—hematologic cancer	7.45e-05	0.000289	CcSEcCtD
Propylthiouracil—TPO—Metabolism—UGT1A1—hematologic cancer	7.44e-05	0.000488	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—GSTP1—hematologic cancer	7.41e-05	0.000486	CbGpPWpGaD
Propylthiouracil—Nausea—Carmustine—hematologic cancer	7.4e-05	0.000287	CcSEcCtD
Propylthiouracil—Vomiting—Irinotecan—hematologic cancer	7.36e-05	0.000286	CcSEcCtD
Propylthiouracil—Vomiting—Mitoxantrone—hematologic cancer	7.36e-05	0.000286	CcSEcCtD
Propylthiouracil—Nausea—Alitretinoin—hematologic cancer	7.33e-05	0.000284	CcSEcCtD
Propylthiouracil—Agranulocytosis—Doxorubicin—hematologic cancer	7.31e-05	0.000284	CcSEcCtD
Propylthiouracil—Rash—Irinotecan—hematologic cancer	7.3e-05	0.000283	CcSEcCtD
Propylthiouracil—Rash—Mitoxantrone—hematologic cancer	7.3e-05	0.000283	CcSEcCtD
Propylthiouracil—Dermatitis—Mitoxantrone—hematologic cancer	7.29e-05	0.000283	CcSEcCtD
Propylthiouracil—Dermatitis—Irinotecan—hematologic cancer	7.29e-05	0.000283	CcSEcCtD
Propylthiouracil—DBH—Metabolism—NUP98—hematologic cancer	7.27e-05	0.000477	CbGpPWpGaD
Propylthiouracil—Headache—Mitoxantrone—hematologic cancer	7.25e-05	0.000282	CcSEcCtD
Propylthiouracil—Headache—Irinotecan—hematologic cancer	7.25e-05	0.000282	CcSEcCtD
Propylthiouracil—Nausea—Ifosfamide—hematologic cancer	7.24e-05	0.000281	CcSEcCtD
Propylthiouracil—TPO—Metabolism—CRABP1—hematologic cancer	7.24e-05	0.000475	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SLC22A1—hematologic cancer	7.24e-05	0.000475	CbGpPWpGaD
Propylthiouracil—Musculoskeletal discomfort—Betamethasone—hematologic cancer	7.22e-05	0.00028	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	7.22e-05	0.00028	CcSEcCtD
Propylthiouracil—Arthralgia—Prednisone—hematologic cancer	7.2e-05	0.000279	CcSEcCtD
Propylthiouracil—Myalgia—Prednisone—hematologic cancer	7.2e-05	0.000279	CcSEcCtD
Propylthiouracil—Alopecia—Methotrexate—hematologic cancer	7.18e-05	0.000278	CcSEcCtD
Propylthiouracil—Vomiting—Gemcitabine—hematologic cancer	7.17e-05	0.000278	CcSEcCtD
Propylthiouracil—Paraesthesia—Dexamethasone—hematologic cancer	7.12e-05	0.000276	CcSEcCtD
Propylthiouracil—Paraesthesia—Betamethasone—hematologic cancer	7.12e-05	0.000276	CcSEcCtD
Propylthiouracil—Rash—Gemcitabine—hematologic cancer	7.11e-05	0.000276	CcSEcCtD
Propylthiouracil—Dermatitis—Gemcitabine—hematologic cancer	7.11e-05	0.000276	CcSEcCtD
Propylthiouracil—Haemoglobin—Doxorubicin—hematologic cancer	7.07e-05	0.000274	CcSEcCtD
Propylthiouracil—Headache—Gemcitabine—hematologic cancer	7.07e-05	0.000274	CcSEcCtD
Propylthiouracil—Nausea—Vincristine—hematologic cancer	7.06e-05	0.000274	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ADCY7—hematologic cancer	7.06e-05	0.000463	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NCOA3—hematologic cancer	7.06e-05	0.000463	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALOX5—hematologic cancer	7.06e-05	0.000463	CbGpPWpGaD
Propylthiouracil—Haemorrhage—Doxorubicin—hematologic cancer	7.03e-05	0.000273	CcSEcCtD
Propylthiouracil—Hepatitis—Doxorubicin—hematologic cancer	7.03e-05	0.000273	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ABCB1—hematologic cancer	7.01e-05	0.00046	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NUP214—hematologic cancer	7.01e-05	0.00046	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Dexamethasone—hematologic cancer	6.98e-05	0.000271	CcSEcCtD
Propylthiouracil—Dyspepsia—Betamethasone—hematologic cancer	6.98e-05	0.000271	CcSEcCtD
Propylthiouracil—Urticaria—Triamcinolone—hematologic cancer	6.94e-05	0.000269	CcSEcCtD
Propylthiouracil—Dysgeusia—Methotrexate—hematologic cancer	6.92e-05	0.000269	CcSEcCtD
Propylthiouracil—Body temperature increased—Triamcinolone—hematologic cancer	6.91e-05	0.000268	CcSEcCtD
Propylthiouracil—Oedema—Prednisone—hematologic cancer	6.9e-05	0.000268	CcSEcCtD
Propylthiouracil—Nausea—Mitoxantrone—hematologic cancer	6.88e-05	0.000267	CcSEcCtD
Propylthiouracil—Nausea—Irinotecan—hematologic cancer	6.88e-05	0.000267	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ABCG2—hematologic cancer	6.86e-05	0.00045	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—MTR—hematologic cancer	6.86e-05	0.00045	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NUP98—hematologic cancer	6.83e-05	0.000448	CbGpPWpGaD
Propylthiouracil—Pruritus—Etoposide—hematologic cancer	6.81e-05	0.000264	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—GSTM1—hematologic cancer	6.81e-05	0.000447	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—NCOR1—hematologic cancer	6.81e-05	0.000447	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ENO2—hematologic cancer	6.73e-05	0.000441	CbGpPWpGaD
Propylthiouracil—Alopecia—Epirubicin—hematologic cancer	6.71e-05	0.000261	CcSEcCtD
Propylthiouracil—Nausea—Gemcitabine—hematologic cancer	6.7e-05	0.00026	CcSEcCtD
Propylthiouracil—Vomiting—Cisplatin—hematologic cancer	6.68e-05	0.000259	CcSEcCtD
Propylthiouracil—TPO—Metabolism—NCOA3—hematologic cancer	6.63e-05	0.000435	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ADCY7—hematologic cancer	6.63e-05	0.000435	CbGpPWpGaD
Propylthiouracil—Rash—Cisplatin—hematologic cancer	6.63e-05	0.000257	CcSEcCtD
Propylthiouracil—Dermatitis—Cisplatin—hematologic cancer	6.62e-05	0.000257	CcSEcCtD
Propylthiouracil—TPO—Metabolism—NUP214—hematologic cancer	6.59e-05	0.000432	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTT1—hematologic cancer	6.53e-05	0.000428	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Epirubicin—hematologic cancer	6.48e-05	0.000251	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ABCG2—hematologic cancer	6.45e-05	0.000423	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—MTR—hematologic cancer	6.45e-05	0.000423	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—SDC1—hematologic cancer	6.38e-05	0.000419	CbGpPWpGaD
Propylthiouracil—Vertigo—Methotrexate—hematologic cancer	6.35e-05	0.000246	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ENO2—hematologic cancer	6.33e-05	0.000415	CbGpPWpGaD
Propylthiouracil—Leukopenia—Methotrexate—hematologic cancer	6.33e-05	0.000246	CcSEcCtD
Propylthiouracil—Urticaria—Dexamethasone—hematologic cancer	6.3e-05	0.000244	CcSEcCtD
Propylthiouracil—Urticaria—Betamethasone—hematologic cancer	6.3e-05	0.000244	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Prednisone—hematologic cancer	6.29e-05	0.000244	CcSEcCtD
Propylthiouracil—Body temperature increased—Dexamethasone—hematologic cancer	6.27e-05	0.000243	CcSEcCtD
Propylthiouracil—Body temperature increased—Betamethasone—hematologic cancer	6.27e-05	0.000243	CcSEcCtD
Propylthiouracil—Nausea—Cisplatin—hematologic cancer	6.24e-05	0.000242	CcSEcCtD
Propylthiouracil—Alopecia—Doxorubicin—hematologic cancer	6.21e-05	0.000241	CcSEcCtD
Propylthiouracil—Paraesthesia—Prednisone—hematologic cancer	6.2e-05	0.000241	CcSEcCtD
Propylthiouracil—Pruritus—Triamcinolone—hematologic cancer	6.18e-05	0.00024	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTT1—hematologic cancer	6.14e-05	0.000403	CbGpPWpGaD
Propylthiouracil—Vomiting—Etoposide—hematologic cancer	6.12e-05	0.000238	CcSEcCtD
Propylthiouracil—Dyspepsia—Prednisone—hematologic cancer	6.08e-05	0.000236	CcSEcCtD
Propylthiouracil—Rash—Etoposide—hematologic cancer	6.07e-05	0.000236	CcSEcCtD
Propylthiouracil—Dermatitis—Etoposide—hematologic cancer	6.07e-05	0.000235	CcSEcCtD
Propylthiouracil—Headache—Etoposide—hematologic cancer	6.03e-05	0.000234	CcSEcCtD
Propylthiouracil—Arthralgia—Methotrexate—hematologic cancer	6.02e-05	0.000234	CcSEcCtD
Propylthiouracil—Myalgia—Methotrexate—hematologic cancer	6.02e-05	0.000234	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—MTHFR—hematologic cancer	6.02e-05	0.000395	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—SDC1—hematologic cancer	6e-05	0.000394	CbGpPWpGaD
Propylthiouracil—Dysgeusia—Doxorubicin—hematologic cancer	5.99e-05	0.000233	CcSEcCtD
Propylthiouracil—Rash—Prednisolone—hematologic cancer	5.99e-05	0.000232	CcSEcCtD
Propylthiouracil—Dermatitis—Prednisolone—hematologic cancer	5.98e-05	0.000232	CcSEcCtD
Propylthiouracil—Headache—Prednisolone—hematologic cancer	5.95e-05	0.000231	CcSEcCtD
Propylthiouracil—Vertigo—Epirubicin—hematologic cancer	5.94e-05	0.000231	CcSEcCtD
Propylthiouracil—Leukopenia—Epirubicin—hematologic cancer	5.92e-05	0.00023	CcSEcCtD
Propylthiouracil—Nausea—Etoposide—hematologic cancer	5.72e-05	0.000222	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Methotrexate—hematologic cancer	5.65e-05	0.000219	CcSEcCtD
Propylthiouracil—Nausea—Prednisolone—hematologic cancer	5.64e-05	0.000219	CcSEcCtD
Propylthiouracil—Myalgia—Epirubicin—hematologic cancer	5.63e-05	0.000219	CcSEcCtD
Propylthiouracil—Arthralgia—Epirubicin—hematologic cancer	5.63e-05	0.000219	CcSEcCtD
Propylthiouracil—Pruritus—Dexamethasone—hematologic cancer	5.61e-05	0.000218	CcSEcCtD
Propylthiouracil—Pruritus—Betamethasone—hematologic cancer	5.61e-05	0.000218	CcSEcCtD
Propylthiouracil—Vomiting—Triamcinolone—hematologic cancer	5.55e-05	0.000216	CcSEcCtD
Propylthiouracil—Rash—Triamcinolone—hematologic cancer	5.51e-05	0.000214	CcSEcCtD
Propylthiouracil—Dermatitis—Triamcinolone—hematologic cancer	5.5e-05	0.000214	CcSEcCtD
Propylthiouracil—Vertigo—Doxorubicin—hematologic cancer	5.5e-05	0.000213	CcSEcCtD
Propylthiouracil—Urticaria—Prednisone—hematologic cancer	5.48e-05	0.000213	CcSEcCtD
Propylthiouracil—Leukopenia—Doxorubicin—hematologic cancer	5.48e-05	0.000213	CcSEcCtD
Propylthiouracil—Headache—Triamcinolone—hematologic cancer	5.47e-05	0.000212	CcSEcCtD
Propylthiouracil—Body temperature increased—Prednisone—hematologic cancer	5.46e-05	0.000212	CcSEcCtD
Propylthiouracil—DBH—Metabolism—NQO1—hematologic cancer	5.43e-05	0.000356	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CD44—hematologic cancer	5.43e-05	0.000356	CbGpPWpGaD
Propylthiouracil—Oedema—Epirubicin—hematologic cancer	5.4e-05	0.00021	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Epirubicin—hematologic cancer	5.29e-05	0.000205	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Methotrexate—hematologic cancer	5.26e-05	0.000204	CcSEcCtD
Propylthiouracil—Myalgia—Doxorubicin—hematologic cancer	5.21e-05	0.000202	CcSEcCtD
Propylthiouracil—Arthralgia—Doxorubicin—hematologic cancer	5.21e-05	0.000202	CcSEcCtD
Propylthiouracil—Nausea—Triamcinolone—hematologic cancer	5.19e-05	0.000201	CcSEcCtD
Propylthiouracil—Paraesthesia—Methotrexate—hematologic cancer	5.18e-05	0.000201	CcSEcCtD
Propylthiouracil—DBH—Metabolism—CYCS—hematologic cancer	5.13e-05	0.000337	CbGpPWpGaD
Propylthiouracil—Somnolence—Methotrexate—hematologic cancer	5.13e-05	0.000199	CcSEcCtD
Propylthiouracil—TPO—Metabolism—NQO1—hematologic cancer	5.1e-05	0.000335	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—HSP90AA1—hematologic cancer	5.1e-05	0.000335	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CD44—hematologic cancer	5.1e-05	0.000335	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Methotrexate—hematologic cancer	5.08e-05	0.000197	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PIK3CG—hematologic cancer	5.05e-05	0.000332	CbGpPWpGaD
Propylthiouracil—Vomiting—Dexamethasone—hematologic cancer	5.04e-05	0.000196	CcSEcCtD
Propylthiouracil—Vomiting—Betamethasone—hematologic cancer	5.04e-05	0.000196	CcSEcCtD
Propylthiouracil—Rash—Betamethasone—hematologic cancer	5e-05	0.000194	CcSEcCtD
Propylthiouracil—Rash—Dexamethasone—hematologic cancer	5e-05	0.000194	CcSEcCtD
Propylthiouracil—Oedema—Doxorubicin—hematologic cancer	5e-05	0.000194	CcSEcCtD
Propylthiouracil—Dermatitis—Dexamethasone—hematologic cancer	4.99e-05	0.000194	CcSEcCtD
Propylthiouracil—Dermatitis—Betamethasone—hematologic cancer	4.99e-05	0.000194	CcSEcCtD
Propylthiouracil—Headache—Dexamethasone—hematologic cancer	4.97e-05	0.000193	CcSEcCtD
Propylthiouracil—Headache—Betamethasone—hematologic cancer	4.97e-05	0.000193	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Epirubicin—hematologic cancer	4.92e-05	0.000191	CcSEcCtD
Propylthiouracil—Thrombocytopenia—Doxorubicin—hematologic cancer	4.89e-05	0.00019	CcSEcCtD
Propylthiouracil—Pruritus—Prednisone—hematologic cancer	4.88e-05	0.00019	CcSEcCtD
Propylthiouracil—Paraesthesia—Epirubicin—hematologic cancer	4.85e-05	0.000188	CcSEcCtD
Propylthiouracil—TPO—Metabolism—CYCS—hematologic cancer	4.83e-05	0.000317	CbGpPWpGaD
Propylthiouracil—Somnolence—Epirubicin—hematologic cancer	4.8e-05	0.000186	CcSEcCtD
Propylthiouracil—TPO—Metabolism—HSP90AA1—hematologic cancer	4.8e-05	0.000315	CbGpPWpGaD
Propylthiouracil—Dyspepsia—Epirubicin—hematologic cancer	4.75e-05	0.000184	CcSEcCtD
Propylthiouracil—Nausea—Betamethasone—hematologic cancer	4.71e-05	0.000183	CcSEcCtD
Propylthiouracil—Nausea—Dexamethasone—hematologic cancer	4.71e-05	0.000183	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—CREBBP—hematologic cancer	4.69e-05	0.000307	CbGpPWpGaD
Propylthiouracil—Urticaria—Methotrexate—hematologic cancer	4.58e-05	0.000178	CcSEcCtD
Propylthiouracil—Body temperature increased—Methotrexate—hematologic cancer	4.56e-05	0.000177	CcSEcCtD
Propylthiouracil—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	4.55e-05	0.000177	CcSEcCtD
Propylthiouracil—DBH—Metabolism—GSTP1—hematologic cancer	4.53e-05	0.000297	CbGpPWpGaD
Propylthiouracil—Paraesthesia—Doxorubicin—hematologic cancer	4.49e-05	0.000174	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PIK3CD—hematologic cancer	4.44e-05	0.000291	CbGpPWpGaD
Propylthiouracil—Somnolence—Doxorubicin—hematologic cancer	4.44e-05	0.000172	CcSEcCtD
Propylthiouracil—Dyspepsia—Doxorubicin—hematologic cancer	4.4e-05	0.000171	CcSEcCtD
Propylthiouracil—Vomiting—Prednisone—hematologic cancer	4.39e-05	0.00017	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—ALB—hematologic cancer	4.39e-05	0.000288	CbGpPWpGaD
Propylthiouracil—Rash—Prednisone—hematologic cancer	4.35e-05	0.000169	CcSEcCtD
Propylthiouracil—Dermatitis—Prednisone—hematologic cancer	4.35e-05	0.000169	CcSEcCtD
Propylthiouracil—Headache—Prednisone—hematologic cancer	4.32e-05	0.000168	CcSEcCtD
Propylthiouracil—Urticaria—Epirubicin—hematologic cancer	4.29e-05	0.000166	CcSEcCtD
Propylthiouracil—DBH—Metabolism—ABCB1—hematologic cancer	4.28e-05	0.000281	CbGpPWpGaD
Propylthiouracil—Body temperature increased—Epirubicin—hematologic cancer	4.27e-05	0.000166	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTP1—hematologic cancer	4.25e-05	0.000279	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3R1—hematologic cancer	4.2e-05	0.000275	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—GSTM1—hematologic cancer	4.16e-05	0.000273	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—NCOR1—hematologic cancer	4.16e-05	0.000273	CbGpPWpGaD
Propylthiouracil—Nausea—Prednisone—hematologic cancer	4.1e-05	0.000159	CcSEcCtD
Propylthiouracil—Pruritus—Methotrexate—hematologic cancer	4.08e-05	0.000158	CcSEcCtD
Propylthiouracil—TPO—Metabolism—ABCB1—hematologic cancer	4.03e-05	0.000264	CbGpPWpGaD
Propylthiouracil—Urticaria—Doxorubicin—hematologic cancer	3.97e-05	0.000154	CcSEcCtD
Propylthiouracil—Body temperature increased—Doxorubicin—hematologic cancer	3.95e-05	0.000153	CcSEcCtD
Propylthiouracil—TPO—Metabolism—GSTM1—hematologic cancer	3.91e-05	0.000256	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—NCOR1—hematologic cancer	3.91e-05	0.000256	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CB—hematologic cancer	3.87e-05	0.000254	CbGpPWpGaD
Propylthiouracil—Pruritus—Epirubicin—hematologic cancer	3.82e-05	0.000148	CcSEcCtD
Propylthiouracil—DBH—Metabolism—MTHFR—hematologic cancer	3.68e-05	0.000241	CbGpPWpGaD
Propylthiouracil—Vomiting—Methotrexate—hematologic cancer	3.67e-05	0.000142	CcSEcCtD
Propylthiouracil—Rash—Methotrexate—hematologic cancer	3.64e-05	0.000141	CcSEcCtD
Propylthiouracil—Dermatitis—Methotrexate—hematologic cancer	3.63e-05	0.000141	CcSEcCtD
Propylthiouracil—Headache—Methotrexate—hematologic cancer	3.61e-05	0.00014	CcSEcCtD
Propylthiouracil—Pruritus—Doxorubicin—hematologic cancer	3.53e-05	0.000137	CcSEcCtD
Propylthiouracil—TPO—Metabolism—MTHFR—hematologic cancer	3.46e-05	0.000227	CbGpPWpGaD
Propylthiouracil—Vomiting—Epirubicin—hematologic cancer	3.43e-05	0.000133	CcSEcCtD
Propylthiouracil—Nausea—Methotrexate—hematologic cancer	3.43e-05	0.000133	CcSEcCtD
Propylthiouracil—Rash—Epirubicin—hematologic cancer	3.4e-05	0.000132	CcSEcCtD
Propylthiouracil—Dermatitis—Epirubicin—hematologic cancer	3.4e-05	0.000132	CcSEcCtD
Propylthiouracil—Headache—Epirubicin—hematologic cancer	3.38e-05	0.000131	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—PTEN—hematologic cancer	3.35e-05	0.00022	CbGpPWpGaD
Propylthiouracil—Nausea—Epirubicin—hematologic cancer	3.21e-05	0.000124	CcSEcCtD
Propylthiouracil—DIO1—Metabolism—EP300—hematologic cancer	3.19e-05	0.000209	CbGpPWpGaD
Propylthiouracil—Vomiting—Doxorubicin—hematologic cancer	3.18e-05	0.000123	CcSEcCtD
Propylthiouracil—Rash—Doxorubicin—hematologic cancer	3.15e-05	0.000122	CcSEcCtD
Propylthiouracil—Dermatitis—Doxorubicin—hematologic cancer	3.15e-05	0.000122	CcSEcCtD
Propylthiouracil—Headache—Doxorubicin—hematologic cancer	3.13e-05	0.000121	CcSEcCtD
Propylthiouracil—DBH—Metabolism—PIK3CG—hematologic cancer	3.09e-05	0.000203	CbGpPWpGaD
Propylthiouracil—Nausea—Doxorubicin—hematologic cancer	2.97e-05	0.000115	CcSEcCtD
Propylthiouracil—TPO—Metabolism—PIK3CG—hematologic cancer	2.9e-05	0.00019	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—CREBBP—hematologic cancer	2.86e-05	0.000188	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CD—hematologic cancer	2.71e-05	0.000178	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—CREBBP—hematologic cancer	2.69e-05	0.000177	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—ALB—hematologic cancer	2.68e-05	0.000176	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3R1—hematologic cancer	2.56e-05	0.000168	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CD—hematologic cancer	2.55e-05	0.000167	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—ALB—hematologic cancer	2.52e-05	0.000165	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3R1—hematologic cancer	2.41e-05	0.000158	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CB—hematologic cancer	2.37e-05	0.000155	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—PIK3CA—hematologic cancer	2.36e-05	0.000155	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CB—hematologic cancer	2.22e-05	0.000146	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PTEN—hematologic cancer	2.04e-05	0.000134	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—EP300—hematologic cancer	1.95e-05	0.000128	CbGpPWpGaD
Propylthiouracil—DIO1—Metabolism—AKT1—hematologic cancer	1.93e-05	0.000127	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PTEN—hematologic cancer	1.92e-05	0.000126	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—EP300—hematologic cancer	1.83e-05	0.00012	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—PIK3CA—hematologic cancer	1.44e-05	9.46e-05	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—PIK3CA—hematologic cancer	1.36e-05	8.89e-05	CbGpPWpGaD
Propylthiouracil—DBH—Metabolism—AKT1—hematologic cancer	1.18e-05	7.73e-05	CbGpPWpGaD
Propylthiouracil—TPO—Metabolism—AKT1—hematologic cancer	1.11e-05	7.27e-05	CbGpPWpGaD
